Physician profile
Judith Forster
NPI 1598828931
$433.91
in general payments reported to CMS, 2019-2025
14 companies · $84.54 in 2025
The $84.54 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.81 · 2020: $26.16 · 2021: $15.00 · 2022: $128 · 2023: $105 · 2024: $27.80 · 2025: $84.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $217.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $76.01 | 2021-2023 | Aplenzin, Wellbutrin |
| Amag Pharmaceuticals, INC. | $46.81 | 2019 | |
| Hologic Sales and Service, LLC | $40.42 | 2025 | Novasure |
| Avion Pharmaceuticals | $38.14 | 2020-2022 | |
| Scynexis, INC. | $32.41 | 2022 | |
| Pfizer INC. | $29.88 | 2022 | |
| Abbvie INC. | $29.30 | 2022-2023 | |
| Millicent US INC | $28.80 | 2020-2025 | Intrarosa |
| Exact Sciences Corporation | $28.59 | 2023-2025 | Cologuard Collection Kit |
| Exeltis, USA INC. | $27.86 | 2023 | Slynd |
| Agile Therapeutics, INC. | $16.12 | 2024 | Twirla |
| Astellas Pharma US INC | $13.99 | 2025 | Veozah |
| Acelrx Pharmaceuticals, INC. | $13.90 | 2022 | |
| Mayne Pharma Commercial LLC | $11.68 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Forster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.